Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Dyslipidemia of Obesity Intervention in Teens

ClinicalTrials.gov ID: NCT02956590

Public ClinicalTrials.gov record NCT02956590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 3:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Dyslipidemia of Obesity Intervention in Teens Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial of pitavastatin will determine efficacy and safety in this high risk population and provide evidence for clinicians to target this treatable risk factor to achieve an impact on early atherosclerosis, and potentially achieve primary prevention of adult cardiovascular disease.

Study identification

NCT ID
NCT02956590
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Carelon Research
Other
Enrollment
122 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
10 Years to 19 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2018
Primary completion
Apr 20, 2023
Completion
Jun 29, 2023
Last update posted
Jul 4, 2024

2018 – 2023

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Nemours/Alfred I duPont Hospital for Children Wilmington Delaware 19803
Children's National Health System Washington D.C. District of Columbia 20010
Emory University School of Medicine Atlanta Georgia 30322
Riley Hospital for Children at IU Health Indianapolis Indiana 46202
Johns Hopkins University School of Medicine Baltimore Maryland 21287
Boston Children's Hospital Boston Massachusetts 02114
Children's Mercy Hospital Kansas City Missouri 64108
Washington University School of Medicine St Louis Missouri 63110
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Medical University of South Carolina Charleston South Carolina 29425
Texas Children's Hospital Houston Texas 77030
Primary Children's Hospital, University of Utah Salt Lake City Utah 84108
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02956590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 4, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02956590 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →